Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Drug development cannot thrive without them, argues the CEO of Human Genome Sciences
Fierce competition, radical expansion, a dubious funding model and maybe even a new director spell the end of an era. Can a trailblazing enterprise survive and thrive?
Handheld devices are taking computers from personal to intimate. A new generation of wireless network is coming that could keep everyone connected all the time.
We rank the top U.S. universities in their quest for intellectual property, commercial partners and profits.
The Human Genome Project is as good as done, says MIT’s Eric Lander. Now it’s time to start thinking about how the data will be used.
The Human Genome Project is in the news. But entrepreneurs are already catching the next wave - 3-D protein structures. The payoff will be drug discovery at genomic speed.
Get ready for optical switching in the telecommunications network backbone, then an all-optical Internet, and finally optical integrated circuits. The amount of data we can get almost anywhere will skyrocket.
Forget those single-purpose e-book readers. The future of electronic publishing lies in files you can download to, view on and print out from the computer you already own.
In the 1990s U.S. companies cut costs, jettisoned marginal efforts, bolstered internal cooperation and formed strategic alliances. Hold on to your hats - universities are set to do the same.
Seeing is no longer believing. The image you see on the evening news could well be a fake - a fabrication of fast new video-manipulation technology.